BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 89 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,594,492 | -42.1% | 555,572 | +1.9% | 0.19% | -56.2% |
| Q2 2023 | $2,752,770 | +524.2% | 545,103 | +242.0% | 0.44% | +655.2% |
| Q1 2022 | $441,000 | -44.9% | 159,390 | +5.9% | 0.06% | -51.3% |
| Q4 2021 | $801,000 | -37.0% | 150,484 | 0.0% | 0.12% | +32.2% |
| Q3 2021 | $1,272,000 | -32.2% | 150,484 | -2.2% | 0.09% | -40.8% |
| Q2 2021 | $1,876,000 | -49.8% | 153,941 | 0.0% | 0.15% | +20.6% |
| Q1 2021 | $3,735,000 | -60.4% | 153,941 | -47.6% | 0.13% | -69.6% |
| Q4 2020 | $9,421,000 | -13.2% | 293,941 | -18.1% | 0.42% | -47.1% |
| Q3 2020 | $10,851,000 | +45.0% | 358,941 | +102.2% | 0.78% | +31.7% |
| Q2 2020 | $7,485,000 | – | 177,544 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |